Related references
Note: Only part of the references are listed.Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first-line treatment for advanced non-small cell lung cancer
Alessandro Rizzo
THORACIC CANCER (2022)
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Takaya Yamamoto et al.
BMC CANCER (2022)
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
Yi-Long Wu et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Hisashi Saji et al.
LANCET (2022)
Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
Alessandro Rizzo et al.
CANCERS (2022)
Efficacy of thymosin α1 in management of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)
Fangjie Liu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)
Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis
Wei Jiang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy
Takanori Adachi et al.
MEDICAL PHYSICS (2021)
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Enriqueta Felip et al.
LANCET (2021)
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
Joe Y. Chang et al.
LANCET ONCOLOGY (2021)
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
Janna Berg et al.
FRONTIERS IN ONCOLOGY (2021)
The dose–response characteristics of four NTCP models: using a novel CT-based radiomic method to quantify radiation-induced lung density changes
Dustin Begosh-Mayne et al.
Scientific Reports (2020)
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
Giuseppe Lamberti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
David Ball et al.
LANCET ONCOLOGY (2019)
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
Yosef Landman et al.
JOURNAL OF ONCOLOGY (2019)
Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images
Takaya Yamamoto et al.
CLINICAL LUNG CANCER (2018)
Association of current and former smoking with body mass index: A study of smoking discordant twin pairs from 21 twin cohorts
Maarit Piirtola et al.
PLOS ONE (2018)
Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer
Takaya Yamamoto et al.
PLOS ONE (2018)
Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters
Anne G. H. Niezink et al.
ONCOLOGIST (2017)
The first patient treatment of computed tomography ventilation functional image-guided radiotherapy for lung cancer
Tokihiro Yamamoto et al.
RADIOTHERAPY AND ONCOLOGY (2016)
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
Gregory M. M. Videtic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
Yasushi Nagata et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival
Brandon Stone et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Pulmonary Ventilation Imaging Based on 4-Dimensional Computed Tomography: Comparison With Pulmonary Function Tests and SPECT Ventilation Images
Tokihiro Yamamoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics
Dirk De Ruysscher et al.
ACTA ONCOLOGICA (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Lack of a Dose-Effect Relationship for Pulmonary Function Changes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Matthias Guckenberger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Changes in Pulmonary Function After Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer
Jose L. Lopez Guerra et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Quantitative CT measures of emphysema and airway wall thickness are related to DLCO
Thomas B. Grydeland et al.
RESPIRATORY MEDICINE (2011)
EARLY GRAPHICAL APPEARANCE OF RADIATION PNEUMONITIS CORRELATES WITH THE SEVERITY OF RADIATION PNEUMONITIS AFTER STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN PATIENTS WITH LUNG TUMORS
Atsuya Takeda et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Robert Timmerman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
Hideomi Yamashita et al.
RADIATION ONCOLOGY (2010)
Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients
Kevin L. Stephans et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
A prospective study of pulmonary function in Hodgkin's lymphoma patients
A. K. Ng et al.
ANNALS OF ONCOLOGY (2008)
Possible mechanisms underlying the development of cachexia in COPD
P. D. Wagner
EUROPEAN RESPIRATORY JOURNAL (2008)
A challenge to traditional radiation oncology
JF Fowler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Radiation pneumonitis in lung cancer patients: A retrospective study of risk factors and the long-term prognosis
A Inoue et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Share Paper
